drugset / Trial / NCT04846348

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

NCT04846348

Phase 2 Terminated 1 enrolled Joseph Butterfield
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness and tolerability of a novel topical preparation for the treatment of cutaneous lesions of mastocytosis.

Timeline

Start
2021-07-26
Primary completion
2021-09-10
Completion
2021-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cromolyn Small molecule 5 % Topical
Subject Diphenhydramine Unknown 1 % Topical
Subject trolamine salicylate Small molecule 10 % Topical